Table 1 Baseline socio-demographic, clinical and biological characteristics of patients included in the ANRS CO 13 HEPAVIH cohort of HIV-HCV co-infected patients, France, 2006-2008
Total N=1175 | HCV chronically infected patients N=1048 | HCV sustained responders N=127 | |
|---|---|---|---|
Age (years), median (IQR) | 45 (42-48) | 45 (42-48) | 46 (43-49) |
Male gender, N (%) | 825 (70.2) | 735 (70.1) | 90 (70.9) |
BMI (kg/m2), median (IQR) | 21.6 (19.7-24.1) | 21.6 (19.7-24.1) | 22.0 (20.1-24.3) |
High school certificate, N (%) | 302(34) | 260 (33) | 42 (42) |
Employment, N (%) | 481 (49) | 423 (48) | 58 (52) |
Quality of life (WHOQOL), median (IQR) | |||
Physical | 14 (11-16) | 14 (11-16) | 14 (11-16) |
Psychological | 14 (12-17) | 14 (12-17) | 14 (12-16) |
Level of independence | 14 (11-17) | 14 (11-17) | 14 (10-17) |
Social relationship | 14 (12-17) | 14 (11-17) | 15 (12-17) |
Environment | 15 (13-17) | 15 (12-17) | 15 (14-17) |
Spirituality/religion | 14 (12-16) | 14 (12-16) | 14 (12-17) |
Alcohol consumption (gr/day): >20 (women) or >30 (men), N (%) | 120 (10.7) | 109 (10.9) | 11 (8.9) |
Daily cocaine use in the last month, N (%) | 136 (14) | 123 (15) | 13 (13) |
Depressive symptoms (CES-D>17 for men, CES-D>23 for women), N (%) | 379 (41) | 343 (41) | 36 (34) |
HOMA, median (IQR) | 2.0 (1.3-3.4) | 2.1 (1.3-3.5) | 2.1 (1.4-3.1) |
Lipodystrophy, N (%) | 635 (54.0) | 560 (53.4) | 75 (59.1) |
Diabetes, N (%) | 69 (5.9) | 62 (5.9) | 7 (5.5) |
ALT (x normal), median (IQR) | 1.2 (0.8-2.0) | 1.3 (0.9-2.1) | 0.6 (0.4-0.8) |
AST (x normal), median (IQR) | 1.1 (0.8-1.8) | 1.2 (0.8-1.9) | 0.7 (0.5-0.9) |
Hepatitis B surface antigen positive, N (%) | 22 (2.0) | 20 (2.0) | 2 (1.7) |